- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Neurocrine Bioscience's CRENESSITY Becomes Commercially Available in the U.S. | ||
| Do | PTC Therapeutics Submits Vantiquinone NDA to FDA | ||
| Do | Lifecore Biomedical to Provide CDMO Services to Nirsum Labs | ||
| Do | Photys, Novo Nordisk Ink Cardiometabolic Research Pact | ||
| Mi | Trodelvy Granted FDA Breakthrough Therapy Designation | ||
| Mi | Novo Holdings Completes Acquisition of Catalent | ||
| Mi | Merck Enters Exclusive Alliance with Hansoh Pharma for Oral GLP-1 Candidate | ||
| Mi | Adicet Bio Names Dr. Julia Maltzman as Chief Medical Officer | ||
| Mi | Juncell Therapeutics Opens New TIL Manufacturing Facility | ||
| Mi | Samsung Invests in Generate: Biomedicines | ||
| Di | Great Bay Bio Secures Series B Funding to Fuel Global Expansion | ||
| Di | Fresenius Kabi Launches Generic Epinephrine Injection in U.S. | ||
| Di | BioVaxys Acquires Critical Lipid Supply for DPX Platform | ||
| Di | Alphina Therapeutics Appoints Chief Scientific Officer | ||
| Di | RTI Surgical Rebrands as Evergen | ||
| Di | FDA Grants Fast Track Designation to LPCN 1148 as Treatment for Sarcopenia | ||
| Di | Merck Discontinues KeyVibe & KEYFORM Clinical Development Programs | ||
| Mo | VectorY Appoints New CEO | ||
| Mo | Novo Holdings Completes Regulatory Hurdles for Catalent Acquisition | ||
| Mo | Scinai Launches U.S. CDMO to Meet Growing Demand | ||
| Mo | ViroCell Biologics Expands U.S. Business Development Team | ||
| Mo | Innovent and Lilly Partner to Bring Innovative Cancer Treatment to China | ||
| Mo | Single Use Support Names New CEO | ||
| Mo | Novo Nordisk Invests $1.2B to Establish New Production Facility in Denmark | ||
| Mo | AbbVie Agrees to Acquire Nimble Therapeutics |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
